Diagnosis and Management of Mullerian Anomalies Across Differing Resource Settings: Worldwide Adaptations

J Pediatr Adolesc Gynecol. 2022 Oct;35(5):536-540. doi: 10.1016/j.jpag.2022.04.007. Epub 2022 Apr 27.

Abstract

Background: Mullerian anomalies affect 7% of reproductive age women. It is important to have a basic understanding of these conditions, given they can affect women at any stage of life and have potential impacts on fertility and pregnancy. This article seeks to review these anomalies as well as specific diagnostic pitfalls and strategies to approach these conditions in both high- and low-resource environments.

Methods: This review was undertaken with a PubMed focused search, using terms related to the diagnosis and management of Mullerian anomalies in many worldwide settings. Consideration was made to assess the medical resources available in low- and middle-income countries (LMICs), which could impact diagnostic and management decisions, compared with high-income countries (HICs). Concurrent medical conditions and both gynecologic and obstetric outcomes were also searched. Practice recommendations from international societies were also reviewed and compared. Finally, 4 conditions were evaluated more closely to assess management differences based on geographic locations and whether the countries were LMICs or HICs; specifically, those evaluated were lower vaginal atresia, uterovaginal agenesis, bicornuate uterus, and septate uterus.

Discussion: Mullerian anomalies encompass a wide variety of conditions, ranging from subtle anatomic changes without concurrent anomalies to complex conditions, associated with anomalies of the kidney or spine, which could impact the ability to manage certain conditions based on medical resources available geographically. A systematic approach and provider expertise is important for appropriate diagnosis and management, independent of geographic location. Counseling is critical for medical and surgical decision-making and might be limited or guided by the resources available in certain settings or even by existing laws.

Conclusions: Limited outcomes are available among patients with Mullerian anomalies in LMICs; however, the management varies based on the basic tools available to address acute needs, as well as long-term fertility and obstetric concerns. More research is needed in this population, which could help drive the importance of early diagnosis and management not only in HICs but also in LMICs, where individualization strategies are key.

Keywords: Diagnosis; Management; Mullerian anomaly; Uterine anomaly.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Kidney
  • Mullerian Ducts* / abnormalities
  • Pregnancy
  • Urogenital Abnormalities* / diagnosis
  • Urogenital Abnormalities* / surgery
  • Uterus / abnormalities
  • Vagina / abnormalities